share_log

万辰集团:上海信公轶禾企业管理咨询有限公司关于福建万辰生物科技集团股份有限公司2023年第二期限制性股票激励计划首次授予部分第一个归属期归属相关事项之独立财务顾问报告

Fujian Wanchen Biotechnology Group: Shanghai Xingongyiheld Enterprise Management Consulting Co., Ltd.'s independent financial advisor report on the first grant of the second phase of the restricted stock incentive plan for Fujian Wanchen Biotechnology Group Co., Ltd. in 2023 and the independent financial advisor report on the related matters of the first attribution period.

SZSI ·  Aug 23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more